These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 114583)
1. C9 hemolytic activity of the soluble C5b-9 complex of guinea pig complement, analogous to human SC5b-9. Kinoshita T; Hong K; Inoue K J Immunol; 1979 Nov; 123(5):1989-95. PubMed ID: 114583 [No Abstract] [Full Text] [Related]
2. Soluble C5b-9 complex of guinea pig complement: demonstration of its heterogeneity and the mechanism of its C9 hemolytic activity as transfer of reversibly bound C9 molecules from the complex. Kinoshita T; Hong K; Inoue K Mol Immunol; 1981 May; 18(5):423-31. PubMed ID: 7311977 [No Abstract] [Full Text] [Related]
3. Proteolytic transformation of SC5b-9 into an amphiphilic macromolecule resembling the C5b-9 membrane attack complex of complement. Bhakdi S; Bhakdi-Lehnen B; Tranum-Jensen J Immunology; 1979 Aug; 37(4):901-12. PubMed ID: 115783 [TBL] [Abstract][Full Text] [Related]
4. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium. Joiner KA; Tartanian AB; Hammer CH; Schweinle JE J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866 [TBL] [Abstract][Full Text] [Related]
5. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization. Tschopp J; Podack ER; Müller-Eberhard HJ J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819 [TBL] [Abstract][Full Text] [Related]
7. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9. Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861 [TBL] [Abstract][Full Text] [Related]
8. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity. Yamamoto KI J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048 [TBL] [Abstract][Full Text] [Related]
9. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex. Miyama A; Kato T; Horai S; Yokoo J; Kashiba S Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074 [TBL] [Abstract][Full Text] [Related]
10. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a. Hammer CH; Hänsch G; Gresham HD; Shin ML J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934 [TBL] [Abstract][Full Text] [Related]
11. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9. Hu VW; Shin ML J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. Podack ER; Preissner KT; Müller-Eberhard HJ Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. Rollins SA; Zhao J; Ninomiya H; Sims PJ J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395 [TBL] [Abstract][Full Text] [Related]
14. Complement lysis: evidence for an amphiphilic nature of the terminal membrane C5b-9 complex of human complement. Bhakdi S; Bjerrum OJ; Bhakdi-Lehnen B; Tranum-Jensen J J Immunol; 1978 Dec; 121(6):2526-32. PubMed ID: 569173 [TBL] [Abstract][Full Text] [Related]
15. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells. Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186 [No Abstract] [Full Text] [Related]
16. The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel. Bhakdi S; Tranum-Jensen J; Klump O J Immunol; 1980 May; 124(5):2451-7. PubMed ID: 6154104 [TBL] [Abstract][Full Text] [Related]
17. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8. Lehto T; Meri S J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959 [TBL] [Abstract][Full Text] [Related]
18. Proteolysis of the monomeric and dimeric C5b-9 complexes of complement: alteration in the susceptibility to proteases of the C9 subunits associated with C5b-9 dimerization. Yamamoto K; Migita S J Immunol; 1981 Aug; 127(2):423-6. PubMed ID: 7019323 [TBL] [Abstract][Full Text] [Related]
19. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes. Lint TF; Behrends CL; Baker PJ; Gewurz H J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985 [TBL] [Abstract][Full Text] [Related]